In a new study, NIAID researchers analyzed levels of SARS-CoV-2 antigen in blood samples taken from study participants and assessed the association of those levels with disease progression.
ne injection of a candidate monoclonal antibody (mAb) known as L9LS was found to be safe and highly protective in U.S. adults exposed to the malaria parasite, according to results from a NIAID phase 1 clinical trial.
Ultrasound is a noninvasive technique that lets clinicians peer inside the body to monitor health or diagnose disease. Several research groups have been trying to develop approaches that would allow longer-term ultrasound monitoring in various settings via wearable devices.
A new NIH study found that biomarkers present in the blood on the day of a traumatic brain injury (TBI) can accurately predict a patient’s risk of death or severe disability 6 months later.
Research has long supported the notion that music and other kinds of sound can help alleviate acute and chronic pain. In a new study, published in Science, an international team of scientists used mice to explore neural pathways through which sound blunts pain.
Using a new imaging technique, NEI researchers have determined that retinal lesions from vitelliform macular dystrophy (VMD) vary by gene mutation. Addressing these differences may be key in designing effective treatments for this and other rare diseases.
Scientists from NIAID’s Vaccine Research Center and colleagues used cutting-edge technology to reveal new insights into cellular reservoirs of HIV. These new insights could have big implications toward an HIV cure.
Physical activity leads to many molecular changes in the body, but it remains unclear how exercise protects against obesity at a molecular level.
Pregnant women who were exposed to multiple phthalates during pregnancy had an increased risk of preterm birth, according to new research by NIH.
New clinical trial data reveals that while Covid-19 booster vaccinations in adults elicit high levels of neutralizing antibodies against the Omicron variant of SARS-CoV-2, antibody levels decrease substantially within 3 months.